Considering that the patients in the TCGA GBM dataset were not treated with bevacizumab, it is likely that the cooperation of JAG1, NOTCH2, NOTCH3, and angiogenesis affected prognosis differently, depending on the situation. The gene discussed is NOTCH2; the disease is glioblastoma.